NCT02651688View on ClinicalTrials.gov

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 11, 2016

Primary Completion Date

May 2, 2017

Study Completion Date

May 2, 2017

Conditions
Acquired Hypogonadotropic HypogonadismObesity
Interventions
DRUG

Placebo

One matching placebo capsule daily in the morning with approximately 8 ounces of water for up to 12 months.

DRUG

Enclomiphene

Enclomiphene capsule daily in the morning with approximately 8 ounces of water for up to 12 months.

Trial Locations (5)

11530

Garden City

12208

Albany

23507

Norfolk

84065

Riverton

02903

Providence

All Listed Sponsors
lead

Repros Therapeutics Inc.

INDUSTRY

NCT02651688 - A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene | Biotech Hunter | Biotech Hunter